Paper Details

  1. Home
  2. Paper Details

Safety and Efficacy of Simultaneous Inoculations of Pneumococcal and Influenza Vaccines in Patients with Coronary Artery Disease.

Author: DaidaHiroyuki, KiyanagiTakashi, KonishiHakuoh, KurataTakeshi, MiyauchiKatsumi, MiyazakiTetsuro, MorinagaHiroaki, Nishitani-YokoyamaMiho, OkaiIwao, ShimadaKazunori, TamuraHiroshi

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Pneumococcal and influenza infections can cause serious health problems in patients with cardiovascular disease. This study investigated the safety and efficacy of simultaneous inoculation of 23-valent pneumococcal polysaccharide vaccine (PPSV23) and trivalent influenza vaccine (TIV) in patients with coronary artery disease (CAD). The study found that simultaneous inoculation of PPSV23 and TIV was safe and well tolerated in patients with CAD. The study also found that simultaneous inoculation was effective in reducing the risk of pneumococcal and influenza infections in patients with CAD.
Paper Details　
Original Abstract of the Article :
Pneumococcal and influenza infections can cause serious morbidity and mortality in patients with cardiovascular diseases. The purpose of this study was to investigate the safety and efficacy of simultaneous inoculations of 23-valent pneumococcal polysaccharide vaccine (PPSV23) and trivalent influenz...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326172/

データ提供：米国国立医学図書館（NLM）

Protecting Hearts: A Vaccine Oasis in the Desert of Cardiovascular Disease

Cardiovascular diseases are a major health concern, and this research explores the safety and efficacy of simultaneous inoculations of pneumococcal and influenza vaccines in patients with coronary artery disease (CAD). The study aimed to assess the potential benefits of these vaccines in preventing serious infections that can exacerbate CAD.

The researchers found that simultaneous inoculations of pneumococcal and influenza vaccines were safe and effective in patients with CAD, offering a potentially valuable tool for protecting these individuals from serious infections. The study provides evidence that these vaccines can be administered together without compromising safety or efficacy.

A Vaccine Oasis in the Desert

This research offers a beacon of hope in the desert of cardiovascular disease, highlighting the potential benefits of pneumococcal and influenza vaccines for protecting patients with CAD. The study suggests that these vaccines can be safely and effectively administered together, potentially leading to a reduced risk of serious infections and improved health outcomes.

Staying Protected in the Desert

The research emphasizes the importance of vaccination for individuals with CAD, offering a valuable tool for protecting them from serious infections. Consult with a healthcare provider to determine the most appropriate vaccination schedule and ensure that you are receiving the necessary protection.

Dr. Camel's Conclusion

This research provides a valuable oasis of information about the safety and efficacy of pneumococcal and influenza vaccines in patients with CAD. It emphasizes the importance of vaccination for protecting these individuals from serious infections, potentially leading to improved health outcomes.

Date :
  1. Date Completed 2022-01-10
  2. Date Revised 2022-01-10
Further Info :

Pubmed ID

33055462

DOI: Digital Object Identifier

PMC8326172

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.